Controlled release of vancomycin from biodegradable microcapsules

References

• AKOVA, M., 1996, Brain abscesses. CNS Drugs, 6, 358–366.
   Web of Science ®Google Scholar
• ATKINS, T. W., PEACOCK, J. J., and YATES, D. J., 1998, Incorporation and release of vancomycin from poly(D,L-lactide-co-glycolide) microspheres. Journal of Micro-encapsulation, 15, 31–44.
   PubMed Web of Science ®Google Scholar
• BENITA, S., 1996, Microencapsulation Methods and Industrial Applications (New York: Marcell Dekker Inc).
   Google Scholar
• BENOIT, M. A., MOUSSET, B., DELLOYE, C., BOUILLET, R., and GILLARD, J., 1997, Antibiotic-loaded plaster of Paris implants coated with polylactide-co-glycolide as a controlled release delivery system for the treatment of bone infections. International Orthopaedics, 21, 403–408.
   PubMed Web of Science ®Google Scholar
• BREM, H., 1990, Polymer to treat brain tumors. Biomaterials, 11, 699–701.
   PubMed Web of Science ®Google Scholar
• BREM, H., TAMARGO, R. J., OLIVI, A., PINN, M., WEINGARD, J. D., WHARAM, M., and EPSTEIN, J. I., 1994, Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. Journal of Neurosurgery, 80, 283–290.
   PubMed Web of Science ®Google Scholar
• BUAHIN, K. G., and BREM, H., 1995, Interstitial chemotherapy of experimental brain tumors: comparison of intratumoral injection versus polymeric controlled release. Journal of Neurooncology, 26, 103–110.
   PubMed Web of Science ®Google Scholar
• CATELLANI, P., VAONA, G., PLAZZI, P., and COLOMBO, P., 1988, Compressed matrices:formulation and drug release kinetics. Acta Pharmaceutica Technologica, 34, 38–41. CHASIN, M., and LANGER, R., 1990, Biodegradable Polymers as Drug Delivery Systems (NewYork: Marcel Dekker Inc).
   Google Scholar
• CHEUNG, R. P. F., and DIPIRO, J. T., 1986, Vancomycin; an update. Pharmacotherapy,, 6, 153–169.
   PubMed Web of Science ®Google Scholar
• COHEN, S., YOSHIOKA, T., LUCARELLI, M., HWANG, L. H., and LANGER, R., 1991, Controlled drug delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharmaceutical Research, 8, 713–720.
   PubMed Web of Science ®Google Scholar
• CONWAY, B. R., and ALPAR, H. 0., 1996, Double emulsion microencapsulation of proteins as model antigens using polylactide polymers: effect of emulsifier on the microsphere characteristics and release kinetics. European Journal of Pharmaceutics and Biopharmaceutics, 42, 42–48.
   Google Scholar
• CUTRIGHT, D. E., BEASLEY, J. D., and PEREZ, B., 1971, Histologic comparison of polylactic and polyglycolic acid sutures. Oral Surgery, 32, 165.
   PubMedGoogle Scholar
• EWEND, M. G., SAMPATH, P., WILLIAMS, J. A., TYLER, B. M., and BREM, H., 1998, Local delivery of chemotherapy prolongs survival in experimental brain metastases from breast carcinoma. Neurosurgery, 43, 1185–1189.
   PubMed Web of Science ®Google Scholar
• FUNG, L. K., EWEND, M. G., SILLS, A., SIPOS, E. P., THOMPSON, R., WATTS, M., COLVIN, 0. M., BREM, H., and SALTZMAN, W. M., 1998, Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. Cancer Research, 58, 672–684.
   Google Scholar
• GASKILL, S. J., and MARTIN, A. E., 1992, Vancomycin: its effect on intracranial pressure. Pediatric Neurosurgery, 18, 139–143.
   PubMed Web of Science ®Google Scholar
• GILDING, D. K., and REED, A. M., 1979, Biodegradable polymers for use in surgery polylactic/poly(acetic acid) homo and co-polymers: I. Polymer, 20, 1459–1464.
   Web of Science ®Google Scholar
• GUPTA, P. K., JOHNSON, H., and ALLEXON, C., 1993, In vitro and in vivo evaluation of clarithromycin/poly(lactic acid) microspheres for intramuscular drug delivery. Journal of Controlled Release, 26, 229.
   Web of Science ®Google Scholar
• GURSEL, I., and HASIRCI, V., 1995, Proteins and drug release behaviour of PHB and variousP(HB-HV) copolymer microcapsules. Journal of Microencapsulation, 12, 185-193. HELLER, J., 1993, Polymers for controlled parenteral delivery of peptides and proteins.Advances in Drug Delivery Reviews, 10, 163.
   Web of Science ®Google Scholar
• KREWSON, C. E., DAUSE, R., MAK, M., and SALTZMAN, W. M., 1996, Stabilization of nerve growth factor in controlled release polymers and in tissue. journal of Biomaterials Science-Polymer Edition., 8, 103–117
   PubMed Web of Science ®Google Scholar
• KUBO, 0., TAJIKA, Y., MURAGAKI, Y., HIYAMA, H., TAKAKURA, K., YOSHIDA, M., and
   Google Scholar
• KUMAKURA, M., 1994, Local chemotherapy with slowly-releasing anticancer drug-polymers for malignant brain tumors. Journal of Controlled Release, 32, 1–8.KULKARNI, R. K., MOORE, E. G., HEGYELI, A. F., and LEONARD, F., 1971, Biodegradable poly(lactic acid) polymers. Journal of Biomedical Materials Research, 5, 169–181. LANGER, R., 1990, New methods of drug delivery. Science, 249, 1527.
   Google Scholar
• LIN, S. S., UENG, S. W., LIU, S. J., CHAN, E. C., CHAO, E. K., TSAI, C. H., CHEN, K. T., WEI, F. C., and Slim, C. H., 1999, Development of a biodegradable antibiotic delivery system. Clinical Orthopaedics, 362, 240–250.
   Google Scholar
• MAK, M., FUNG, L., STRASSER, J. F., and SALTZMAN, W. M., 1995, Distribution of drugs following controlled delivery to the brain interstitium. Journal of Neurooncology, 26, 91–102.
   PubMed Web of Science ®Google Scholar
• OGAWA, Y., YAMAMATO, M., OKADA, H., YASHIKI, T., and SHIMAMOTO, T. S., 1988, A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic)acid. Chemical and Pharmaceutical Bulletin, 36, 1095–1103.
   PubMed Web of Science ®Google Scholar
• OKADA, H., and Tocucm, H., 1995, Biodegradable microspheres in drug delivery. Critical Reviews in Therapeutic Drug Carrier Systems, 12, 1–99.
   PubMed Web of Science ®Google Scholar
• Omvi, A., EWEND, M. G., UTSUKI, T., TYLER, B., DOMB, A. J., BRAT, D. J., and BREM, H., 1996, Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat. Cancer Chemotherapy and Pharmacology, 39, 90–96.
   PubMed Web of Science ®Google Scholar
• OZALP, Y., 1997, Characterization of vancomycin containing poly(D,L-lactide) implants and investigation of their in vitro-in vivo release behavior. PhD Thesis, Ankara.
   Google Scholar
• PARK, T. G., 1995, Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition. Biomaterials, 16, 1123–1130.
   PubMed Web of Science ®Google Scholar
• RAK, J., FORD, J. L., ROSTON, C., and WALTERS, V., 1985, The preparation and characterization of poly(D,L-lactic acid) for use as biodegradable drug carrier. Pharmaceutica Acta Helvetica, 60, 162–169.
   PubMedGoogle Scholar
• REZA, M. S., and WHATELEY, T. L., 1998, Iodo-2'-deoxyuridine (IudR) and 125IudR loaded biodegradable microspheres for controlled delivery to the brain. Journal of Microencapsulation, 15, 789–801.
   PubMed Web of Science ®Google Scholar
• SALTZMAN, W. M., MAK, M. W., MAHONEY, M. J., DUENAS, E. T., and CLELAND, J. L., 1999, Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems. Pharmaceutical Research, 16, 232–240.
   PubMed Web of Science ®Google Scholar
• SCHROEDER, U., SCHROEDER, H., DARIUS, J., GREKSCH, G., and SABEL, B. A., 1998, Simulation of psychosis by continuous delivery of phencyclidine from controlled-release polymer implants. Behavioural and Brain Research, 97, 59–68.
   PubMed Web of Science ®Google Scholar
• TAMARGO, R. J., MYSEROS, J. S., EPSTEIN, J. I., YANG, M. B., CHASIN, M., and BREA4, H., 1993, Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain. Cancer Research, 53, 329–333.
   Google Scholar
• TAMARGO, R. J., SILLS, A. K., REINHARD, C. S., PINN, D. M., LONG, D. M., and BREA4, H., 1991, Interstitial delivery of dexamethasone in the brain for the reduction of peritumoral edema. Journal of Neurosurgery, 74, 956–961.
   Google Scholar
• WAHLBERG, L. U., ALMQUIST, P. M., GLANTZ, M. J., and BOETHIUS J., 1996, Polymeric controlled release amsacrine chemotherapy in an experimental glioma model. Acta Neurochirurgie, 138, 1329–1330.
   Google Scholar
• WEINGART, J. D., Sims, E. P., and BREM, H., 1995, The role of minocycline in the treatment of intracranial 9L glioma. Journal of Neurosurgery, 82, 635–640.
   PubMed Web of Science ®Google Scholar
• WILLIAMS, J. A., DILLEHAY, L. E., TABASSI, K., SIPOS, E., FAHLMAN, C., and BREM, H., 1997, Implantable, biodegradable polymers for IudR radiosensitization of experimental human malignant glioma. Journal of Neurooncology, 32, 181–192.
   PubMed Web of Science ®Google Scholar
• WILLIAMS, J. A., YUAN, X., DILLEHAY, L. E., SHASTRI, V. R., BREM, H., and WILLIAMS, J. R., 1998, Synthetic, implantable polymers for local delivery of IudR to experimental human malignant glioma. International Journal of Radiation Oncology, Biology, Physics, 42, 631–639.
   PubMed Web of Science ®Google Scholar
• YAN, C., RESAU, J. H., HEWETSON, J., WEST, M., RILL, W. L., and KENDE, M., 1994, Characterization and morphological analysis of protein loaded poly(lactide-co-glycolide) microparticles prepared by water-in-oil-in-water emulsion technique. Journal of Controlled Release, 32, 231–241.
   Web of Science ®Google Scholar